Lonza Group AG (Lonza) is a Swiss company engaged in the chemical and biotechnology sectors. The Company divides its activities into three divisions: Life Science Ingredients, Exclusive Synthesis and Biopharmaceuticals, as well as Bioscience. The Life Science Ingredients division focuses on the provision of ingredients used in nutrition, microbial control and selected industrial markets. The Exclusive Synthesis and Biopharmaceuticals division is a custom manufacturer of advanced intermediates and active ingredients for the healthcare market. These ingredients are used in drugs for the treatment of cardiovascular disease, cancer, neurological and infectious diseases. The Bioscience division provides products and services to support the discovery and commercialization of human therapeutics. Its clients include pharmaceutical and biotechnology companies, as well as academic and government research organizations. Lonza operates through research and production subsidiaries worldwide.